1. Home
  2. GENC vs ABOS Comparison

GENC vs ABOS Comparison

Compare GENC & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

HOLD

Current Price

$14.54

Market Cap

210.0M

Sector

Industrials

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.18

Market Cap

182.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENC
ABOS
Founded
N/A
1996
Country
United States
United States
Employees
318
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.0M
182.0M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
GENC
ABOS
Price
$14.54
$2.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$17.60
$8.00
AVG Volume (30 Days)
15.5K
270.2K
Earning Date
02-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
8.08
N/A
EPS
0.23
N/A
Revenue
$48,943,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$25.51
N/A
P/E Ratio
$62.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.22
$0.99
52 Week High
$17.40
$3.60

Technical Indicators

Market Signals
Indicator
GENC
ABOS
Relative Strength Index (RSI) 46.15 34.07
Support Level $13.82 $1.23
Resistance Level $14.59 $2.42
Average True Range (ATR) 0.52 0.13
MACD -0.04 -0.02
Stochastic Oscillator 23.49 8.40

Price Performance

Historical Comparison
GENC
ABOS

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: